These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21145525)

  • 1. Neuropharmacology in pediatric brain injury: a review.
    Pangilinan PH; Giacoletti-Argento A; Shellhaas R; Hurvitz EA; Hornyak JE
    PM R; 2010 Dec; 2(12):1127-40. PubMed ID: 21145525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of agitation following traumatic brain injury: a review of the literature.
    Levy M; Berson A; Cook T; Bollegala N; Seto E; Tursanski S; Kim J; Sockalingam S; Rajput A; Krishnadev N; Feng C; Bhalerao S
    NeuroRehabilitation; 2005; 20(4):279-306. PubMed ID: 16403996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Agitation in head injury. II. Treatment with antidepressant, sympathomimetic, beta blocker , dopaminergic and other drugs].
    Bascuñana H; Villarreal I; Alfonso S; Terré R; Bernabeu M
    Rev Neurol; 2000 Jun 1-15; 30(11):1044-7. PubMed ID: 10904951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agitation and/or aggression after traumatic brain injury in the pediatric population treated with ziprasidone. Clinical article.
    Scott LK; Green R; McCarthy PJ; Conrad SA
    J Neurosurg Pediatr; 2009 Jun; 3(6):484-7. PubMed ID: 19485732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacotherapy of the cognitive sequelae secondary to traumatic brain injury].
    Riós-Romenets S; Castaño-Monsalve B; Bernabeu-Guitart M
    Rev Neurol; 2007 Nov 1-15; 45(9):563-70. PubMed ID: 17979087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychopharmacological issues in the treatment of TBI and PTSD.
    McAllister TW
    Clin Neuropsychol; 2009 Nov; 23(8):1338-67. PubMed ID: 19882475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of sleep medications on cognitive recovery from traumatic brain injury.
    Larson EB; Zollman FS
    J Head Trauma Rehabil; 2010; 25(1):61-7. PubMed ID: 20051895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amantadine for traumatic brain injury: does it improve cognition and reduce agitation?
    Leone H; Polsonetti BW
    J Clin Pharm Ther; 2005 Apr; 30(2):101-4. PubMed ID: 15811161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drugs for behavior disorders after traumatic brain injury: Systematic review and expert consensus leading to French recommendations for good practice.
    Plantier D; Luauté J;
    Ann Phys Rehabil Med; 2016 Feb; 59(1):42-57. PubMed ID: 26797170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on pharmaceutical intervention for disorders of consciousness and agitation after traumatic brain injury in children.
    Suskauer SJ; Trovato MK
    PM R; 2013 Feb; 5(2):142-7. PubMed ID: 23415249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health care utilization and needs after pediatric traumatic brain injury.
    Slomine BS; McCarthy ML; Ding R; MacKenzie EJ; Jaffe KM; Aitken ME; Durbin DR; Christensen JR; Dorsch AM; Paidas CN;
    Pediatrics; 2006 Apr; 117(4):e663-74. PubMed ID: 16533894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological interventions for agitation in patients with traumatic brain injury: protocol for a systematic review and meta-analysis.
    Williamson DR; Frenette AJ; Burry L; Perreault MM; Charbonney E; Lamontagne F; Potvin MJ; Giguère JF; Mehta S; Bernard F
    Syst Rev; 2016 Nov; 5(1):193. PubMed ID: 27855720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medications prescribed to brain injury patients: a retrospective analysis.
    Han MH; Craig SB; Rutner D; Kapoor N; Ciuffreda KJ; Suchoff IB
    Optometry; 2008 May; 79(5):252-8. PubMed ID: 18436165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-methyl-D-aspartate preconditioning improves short-term motor deficits outcome after mild traumatic brain injury in mice.
    Costa T; Constantino LC; Mendonça BP; Pereira JG; Herculano B; Tasca CI; Boeck CR
    J Neurosci Res; 2010 May; 88(6):1329-37. PubMed ID: 19998488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A descriptive analysis of pharmacological management of aggression and/or agitation in patients with traumatic brain injury in a Southwest Virginia inpatient population.
    Rahmani E; Lemelle T; Sharp H; Smarbafzadeh E; Kablinger A
    J Clin Pharm Ther; 2022 Dec; 47(12):2083-2090. PubMed ID: 36543254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Care management of the agitation or aggressiveness crisis in patients with TBI. Systematic review of the literature and practice recommendations.
    Luauté J; Plantier D; Wiart L; Tell L;
    Ann Phys Rehabil Med; 2016 Feb; 59(1):58-67. PubMed ID: 26700025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive outcome following traumatic brain injury.
    Dikmen SS; Corrigan JD; Levin HS; Machamer J; Stiers W; Weisskopf MG
    J Head Trauma Rehabil; 2009; 24(6):430-8. PubMed ID: 19940676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amantadine enhancement of arousal and cognition after traumatic brain injury.
    Sawyer E; Mauro LS; Ohlinger MJ
    Ann Pharmacother; 2008 Feb; 42(2):247-52. PubMed ID: 18212258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Agitation in head injury. I. Definition and treatment with anxiolytic neuroleptics and antiepileptic drugs].
    Bascuñana H; Villarreal I; Alfonso S; Bernabeu M; Terré R
    Rev Neurol; 2000 May 1-15; 30(9):850-4. PubMed ID: 10870200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychopharmacological treatment of non-comorbid and comorbid pervasive developmental disorder and pediatric bipolar disorder.
    Hamrin V; McDonnell MA; Moffett J; Durso S
    Minerva Pediatr; 2008 Feb; 60(1):87-101. PubMed ID: 18277368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.